Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $65,836 - $272,751
235,131 Added 25.53%
1,156,299 $381,000
Q1 2024

May 10, 2024

BUY
$1.06 - $1.67 $608,544 - $958,745
574,099 Added 165.41%
921,168 $1.07 Million
Q4 2023

Feb 14, 2024

SELL
$1.26 - $1.79 $21,748 - $30,897
-17,261 Reduced 4.74%
347,069 $586,000
Q3 2023

Nov 09, 2023

BUY
$1.61 - $2.54 $308,424 - $486,582
191,568 Added 110.89%
364,330 $659,000
Q2 2023

Aug 09, 2023

SELL
$1.14 - $1.95 $3,394 - $5,807
-2,978 Reduced 1.69%
172,762 $321,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.19 $60,818 - $110,993
-50,682 Reduced 22.38%
175,740 $233,000
Q4 2022

Feb 09, 2023

BUY
$1.63 - $3.52 $109,374 - $236,195
67,101 Added 42.12%
226,422 $382,000
Q3 2022

Nov 09, 2022

SELL
$0.73 - $3.74 $118,854 - $608,924
-162,814 Reduced 50.54%
159,321 $497,000
Q2 2022

Aug 11, 2022

BUY
$2.2 - $4.2 $708,697 - $1.35 Million
322,135 New
322,135 $767,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.